[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337706-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337706-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","interleukin-6-positive-immune-cells-as-a-possible-new-immunologic-marker-associated-with-the-colorectal-cancer-prognosis-abstract","Interleukin-6-Positive Immune Cells as a Possible New Immunologic Marker Associated With the Colorectal Cancer Prognosis - Abstract","","Chronic inflammation shapes the colorectal cancer tumor microenvironment (TME), promoting proliferation, migration, metastasis, and overall tumor progression. Interleukin-6 (IL-6), a pleiotropic proinflammatory cytokine, is investigated for relevance to colorectal cancer (CRC) mechanisms and prognosis. The study evaluates IL-6 expression in both tumor and immune cells, serum IL-6 concentration, and IL6-174 G/C genotype, correlating findings with morphologic and clinical parameters. Data are obtained from 153 CRC patients using ELISA, immunohistochemistry, double immunofluorescence, MSI testing for MMR proteins, and PCR-RFLP genotyping.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/interleukin-6-positive-immune-cells-as-a-possible-new-immunologic-marker-associated-with-the-colorectal-cancer-prognosis-abstract/337706/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/interleukin-6-positive-immune-cells-as-a-possible-new-immunologic-marker-associated-with-the-colorectal-cancer-prognosis-abstract/337706.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does IL-6 play in colorectal cancer according to the document?","Question",{"text":63,"@type":64},"IL-6 is described as a proinflammatory cytokine with pleiotropic effects on colorectal cancer development, influencing processes such as tumor progression within the tumor microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were IL-6 levels and IL-6 expression measured in this study?",{"text":68,"@type":64},"Serum IL-6 concentration was measured by ELISA, while IL-6 expression in tumor and immune cells was assessed using immunohistochemical and double immunofluorescence staining.",{"name":70,"@type":61,"acceptedAnswer":71},"Which IL-6-related results were linked to patient survival?",{"text":72,"@type":64},"Higher IL-6+ immune cells at the invasive front and in tumor-associated areas, especially in early stages without metastases, were associated with longer survival after surgical therapy in the reported analyses.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337706,1790363037,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Interleukin-6-Positive Immune Cells as a Possible New Immunologic Marker Associated With the Colorectal  \nCancer Prognosis  \nMaya Gulubova, MD, PhD,*† Dimitur Chonov, MD,‡ Elina Aleksandrova, PhD,§ Koni Ivanova, MD, PhD,* M. Magdalena Ignatova, MD,* and Tatyana Vlaykova, PhD§∥  \nAbstract: Chronic inﬂammation creates tumor microenvironment (TME) that facilitates colorectal cancer (CRC) cell proliferation, migration, metastasis, and tumor progression. Interleukin-6 (IL-6) is a proinﬂammatory cytokine with a pleiotropic effect on CRC development. We aimed to evaluate IL-6 expression in tumor cells and in immune cells in TME, to assess the serum level and IL6 -174 G/C genotype distribution and to correlate the results with selected morphologic and clinical parameters that may add useful information in understanding the mechanisms of human CRC progression. A total of 153 patients with CRC were recruited in the current study. We assessed the IL-6 serum concentration through the ELISA method, the expression of IL-6 in tumor and in immune cells by immunohistochemical and double immunoﬂuorescence staining, the MSI status by immunоhistochemistry for 4 mismatch repair (MMR) proteins, and the genotype distributions for IL6 -174G/ C (rs1800795) single-nucleotide polymorphism through PCRRFLP method. Our results showed that serum IL-6 level were increased in CRC patients as compared with healthy controls (P \u003C 0.0001), and in patients with cancers with advanced histo-  \nReceived for publication June 2, 2023; accepted March 15, 2024 .  \nFrom the *Department of General and Clinical Pathology, Forensic Medicine and Deontology; ‡Department of Surgery; §Department of Medical Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria; †Department of Anatomy, Histology and Embriology, Pathology, Latin language, Forensic Medicine and Deontology, Faculty of Medicine, University Prof. Dr. Assen Zlatarov, Burgas; and ∥Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, Plovdiv, Bulgaria.  \nThis research was funded by the Bulgarian Ministry of Education and Science (MES) in the frames of the Bulgarian National Recovery and Resilience Plan, Component “Innovative Bulgaria,” Project No. BGRRP-2 .004-0006-C02, “Development of research and innovation at Trakia University in service of health and sustainable well-being.”  \nThe authors declare no conﬂict of interest.  \nReprints: Elina Aleksandrova, PhD, Department of Medical Chemistry and Biochemistry, Medical Faculty, Stara Zagora 6000, Bulgaria (e-mail: elina. [aleksandrova@trakia-uni.bg](aleksandrova@trakia-uni.bg)).  \nCopyright © 2024 The Author(s) . Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.  \nDOI: 10.1097/PAI.0000000000001198  \nlogic type (type IV) . However, the higher concentration (above the median of 55.71 pg/mL) was with borderline association with longer survival of the patients after surgical therapy (P = 0.055, Log rank test) . We also found that IL-6+ immune cells prevailed in the invasive front (IF) of tumors compared with the tumorstroma (TS) (P \u003C 0.0001) . More IL-6+ cells were recruited in the tumors with less advanced histologic type (I+II), with stronger inﬂammatory inﬁltrate in the IF, in early pTNM stages (I+II), without lymph node and distant metastases and the higher levels of IL-6+ cells, especially in the IF, were associated with longer survival (P = 0.012) . The results of our study suggest that although the serum levels of IL-6 are higher in CRC, the increased IL-6+ cells in tumor microenvironment, both in the invasive front and in tumor stroma, as well as the higher serum levels are associated ","cbCaibVRTGzTvZKk","https://ap.wps.com/l/cbCaibVRTGzTvZKk","pdf",647685,11,"English","# Abstract\n## Study aim and rationale\n## Methods and patient cohort\n## Key findings and prognostic associations\n## Keywords","[{\"question\":\"What role does IL-6 play in colorectal cancer according to the document?\",\"answer\":\"IL-6 is described as a proinflammatory cytokine with pleiotropic effects on colorectal cancer development, influencing processes such as tumor progression within the tumor microenvironment.\"},{\"question\":\"How were IL-6 levels and IL-6 expression measured in this study?\",\"answer\":\"Serum IL-6 concentration was measured by ELISA, while IL-6 expression in tumor and immune cells was assessed using immunohistochemical and double immunofluorescence staining.\"},{\"question\":\"Which IL-6-related results were linked to patient survival?\",\"answer\":\"Higher IL-6+ immune cells at the invasive front and in tumor-associated areas, especially in early stages without metastases, were associated with longer survival after surgical therapy in the reported analyses.\"}]","Interleukin-6-Positive Immune Cells as a Possible New Immunologic Marker Associated With the Colorectal Cancer Prognosis - Abstract | PDF",1790020281,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/337125edc092ce00bece0b38ad3a73f0.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2dd683df4acf0d5cf948ef66fb852c83.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b273c26ff424ff1b474a3d0114ece608.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33d8bb42d1c17e8bcf806a1c279a1f05.webp",980,1311]